NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.780
+0.020 (1.14%)
Aug 21, 2026, 9:50 AM EDT - Market open
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $191.39 million as of August 21, 2026. Its market cap has increased by 31.02% in one year.
Market Cap
191.39M
Enterprise Value
130.28M
1-Year Change
31.02%
Ranking
Category
Stock Price
$1.78
ChartMarket Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $191.39M, an increase of 411.33%. That is a compound annual growth rate of 24.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 191.39M | -57.06% |
| Dec 31, 2025 | 445.73M | 190.81% |
| Dec 31, 2024 | 153.27M | 26.05% |
| Dec 29, 2023 | 121.60M | 74.14% |
| Dec 30, 2022 | 69.83M | -27.73% |
| Dec 31, 2021 | 96.62M | 58.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acumen Pharmaceuticals | 198.15M |
| Innate Pharma | 196.48M |
| Corbus Pharmaceuticals Holdings | 194.96M |
| Korro Bio | 194.67M |
| Protalix BioTherapeutics | 188.54M |
| Alpha Cognition | 186.71M |
| MediWound | 175.97M |
| Nkarta | 172.62M |